Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-027683

CEO, Pres, CFO, Treas & Secy bought 10,000 shares at $1.83 ($18,300)

From the SEC's structured data for this filing

Trades in this filing

KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-20 Purchase : show line 1 in the form +10,000 $1.83 $18,300 18,926 D
Open-market purchases · 10,000 sh · avg $1.83 · $18,300
Loading xslF345X03/doc4.xml…